References
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
- FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
- Danish Board of HealthCancerregisteret 2009 [Cancer Registry 2009]CopenhagenDanish Board of Health2010 Danish. Available from: http://www.sst.dk/publ/Publ2010/DOKU/Registre/Cancerregisteret2009.pdfAccessed November 23, 2011
- GreeneFPageDFlemingIAJCC Cancer Staging Manual6th edNew YorkSpringer-Verlag2002
- YoussefRFLotanYPredictors of outcome of non-muscle-invasive and muscle-invasive bladder cancerScientific World Journal20111136938121336453
- Danish Board of HealthKræftplan II [Cancer Plan II; web page on the Internet]CopenhagenDanish Board of Health nd. Available at: http://www.sst.dk/Planlaegning%20og%20kvalitet/Kraeftbehandling/Nationale%20planer/Kraeftplan_II.aspxAccessed November 28, 2011 Danish
- GjerstorffMLThe Danish Cancer RegistryScand J Public Health201139Suppl 7424521775350
- PedersenCBThe Danish Civil Registration SystemScand J Public Health201139Suppl 7222521775345
- StormHHMichelsenEVClemmensenIHPihlJThe Danish Cancer Registry – history, content, quality and useDan Med Bull19974455355399408738
- Danish Board of HealthDet moderniserede Cancerregister – metode og kvalitet [The Modernized Cancer Registry – Methodology and Quality]CopenhagenDanish Board of Health2009 Danish. Available at: http://www.sst.dk/~/media/Indberetning%20og%20statistik/Cancerregisteret/Metodebeskrivelse_publikation%20Cancerregisteret.ashxAccessed April 25, 2012
- LyngeESandegaardJLReboljMThe Danish National Patient RegisterScand J Public Health201139Suppl 7303321775347
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
- ThygesenSKChristiansenCFChristensenSLashTLSorensenHTThe predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Med Res Methodol2011118321619668
- LauECMowatFSKelshMAUse of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims dataClin Epidemiol2011325927222135501
- US National Cancer InstituteSEER Stat Fact Sheets: BladderBethesda, MDUS National Cancer Institute2012 Available from: http://seer.cancer.gov/statfacts/html/urinb.htmlAccessed January 6, 2012
- US National Cancer InstituteSEER registries [database on the Internet]Bethesda, MDUS National Cancer Institute nd. Available from: http://seer.cancer.gov/about/Accessed January 6, 2012
- YuJBGrossCPWilsonLDSmithBDNCI SEER public-use data: applications and limitations in oncology researchOncology (Williston Park)200923328829519418830
- MerrillRMSloanAAndersonAERykerKUnstaged cancer in the United States: a population-based studyBMC Cancer20111140221936934
- KoroukianSMXuFBeairdHDiazMMurrayPRoseJHComplexity of care needs and unstaged cancer in elders: a population-based studyCancer Detect Prev200731319920617658225
- YancikRWesleyMNRiesLAHavlikRJEdwardsBKYatesJWEffect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and olderJAMA2001285788589211180731
- HavlikRJYancikRLongSRiesLEdwardsBThe National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderlyCancer199474Suppl 7210121068087777
- KlassenACCurrieroFKulldorffMAlbergAJPlatzEANelomsSTMissing stage and grade in Maryland prostate cancer surveillance data, 1992–1997Am J Prev Med200630Suppl 2S77S8716458794
- LundLErichsenRNorgaardMLarsenEHBorreMJacobsenJSurvival of invasive bladder cancer patients, 1998–2009; a central and northern Denmark population-based cohort studyClin Epidemiol20113Suppl 1475121814470
- HermannGGHornTStevenKThe influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancerJ Urol1998159191949400444
- YounesMSussmanJTrueLDThe usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladderCancer19906635435482364365
- BassiPFerranteGDPiazzaNPrognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohortJ Urol199916151494149710210380
- BellaAJStittLWChinJLIzawaJIThe prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladderJ Urol20031706 Pt 12253225714634391
- ShariatSFKarakiewiczPIPalapattuGSOutcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research ConsortiumJ Urol20061766 Pt 124142422 Discussion 242217085118
- SternbergCNYagodaAScherHIMethotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer19896412244824582819654
- TürkölmezKTokgözHReşorluBKöseKBedükYMuscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumorsUrology200770347748117905100